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Background: Despite the increasing prevalence of diabetes and other health consequences of obesity, little is
known on the metabolic profile across categories of body mass index (BMI) among African populations. We
therefore assessed the prevalence and distribution of body size phenotypes among urban and rural Cameroonians.
Methods: Adults (n = 1628; 41% rural dwellers) aged 24–74 years in 1994 provided data on BMI and metabolic
health, defined on the basis of elevated levels of blood pressure (BP); triglycerides, fasting plasma glucose (FPG),
and insulin resistance as assessed with homeostasis model assessment (HOMA). Cross-classification of BMI
categories and metabolic status (healthy/unhealthy) created six groups. Metabolic measures include elevated
blood pressure; elevated triglycerides (≥150 mg/dL or 1.69mmo/L), elevated fasting plasma glucose (≥100 mg/dl
or 5.6 mmol/L or documented use of antidiabetic medications), and elevated homeostasis model assessment of
insulin resistance value (HOMA-IR > 90th percentile).
Results: A total of 25.2% of participants were overweight yet metabolically healthy (<1 abnormality) and 10.1% were
obese yet metabolically healthy, whereas 1.4% were normal weight but metabolically abnormal (≥2 abnormalities).
Proportion of rural dwellers with abnormal metabolic phenotype across normal-weight, overweight, obese categories
were 2.9%, 0.8% and 0.3%, respectively; and 0 .3%, 2.2% and 2.6% among urban dwellers. Metabolically abnormal
participants increased linearly across BMI categories (p < 0.001). BMI categories and metabolic status interacted
to affect age, gender, BMI, FPG, triglycerides, and BP status distributions (all p < 0.04). Metabolic status and
residence (rural vs. urban) interacted to influence the distribution across BMI categories of diastolic BP, BMI,
waist circumference, fasting and 2-hour glucose, triglycerides, HOMA-IR, and prevalent diabetes (all p < 0.005),
with differential occurrence of BMI categories and metabolic status among urban and rural participants.
Conclusions: Metabolic healthy obesity and obesity with a favorable cardiometabolic profile are not uncommon
among Cameroonians, including among rural dwellers; but the latter group tended to have a better profile.Background
Obesity is a major precursor of type 2 diabetes mellitus
and several cardiovascular disease (CVD) risk factors in-
cluding hypertension, dyslipidemia and pro-inflammatory
states. There has been an increasing recognition that the
disease risks associated with obesity may not be uniform
[1]. Indeed variations in metabolic and CVD risk factors
have been observed among individuals of similar body
mass index (BMI) [2]. Furthermore studies suggest than* Correspondence: apkengne@yahoo.com
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unless otherwise stated.an individual’s CVD risk may depend jointly on their body
size and metabolic profile [3]. Consequently, there have
been several investigations on body size phenotypes, with
a recognized phenotype being the metabolically healthy
but obese individual, also referred to as “uncomplicated”
obesity [4], which applies to people who although obese
appear to be relatively resistant to the development of the
adiposity-associated metabolic abnormalities that would
increase CVD risk [3]. Another body size phenotype in-
cludes individuals with normal weight, who express meta-
bolic abnormalities often associated with being overweight
and obese [2].
Despite the increasing prevalence of obesity in Africa
population [5], assessment of the aforementioned body
size phenotypes and their implications for disease riskl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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populations [6]. Furthermore, few extant studies have
examined the frequencies of various phenotypes by eth-
nicity, with suggestion of higher prevalence of metabol-
ically healthy obesity among Asians populations [4].
Little is known regarding their prevalence and pattern in
the African context, especially as there may be a rural –
urban divide that may explain the distributions of body
size phenotypes, and accordingly some of the observed
urban-rural differentials in the distribution of major
CVD risk factors in Africa. Therefore, we investigated a
representative sample of adult Cameroonians, in order
to assess: (i) the prevalence of body size phenotypes
(normal weight with and without cardiometabolic abnor-
malities, overweight with and without cardiometabolic
abnormalities, and obese with and without cardiometa-
bolic abnormalities), (ii) the characteristics of expressing
cardiometabolic abnormalities if normal weight, and (iii)
the characteristics of appropriate metabolically health
(no cardiometabolic risk factor clustering) if overweight
or obese.
Methods
Study participants
The study was a cross-sectional survey conducted in 1994
among Cameroonians, in three villages of the Evodoula
(rural) and the Cité Verte (urban) health areas. All inhabi-
tants, aged between 24 and 74 years and who had been
residents at the sites for at least 1 year before the surveys
were recruited through a simple probability sampling de-
sign. The response rates were 95 and 91% in the rural and
urban sites, respectively. Of the 1986 participants (786
rural and 1160 urban subjects), complete data on variables
of interest were available for 1628 (669 rural and 959
urban subjects) participants, thus constituting the final
sample. The study procedures have been described in de-
tails previously [7]. All individuals gave informed consent
to participate. The studies were approved by relevant eth-
ics committees in Cameroon, and conformed to the prin-
ciples outlined in the declaration of Helsinki.
Measurement of demographic, health and physical
factors
Age, sex, educational level, smoking status, alcohol intake,
physical activity, history of hypertension or diabetes, as
well as the use of antihypertensive, lipid-lowering, and an-
tidiabetic medications were assessed by self-report. Smok-
ing status was categorized as non-smoker (had never
smoked), ex-smoker (had stopped smoking for at least
one year) and smokers (current smokers). Alcohol con-
sumption was based on the intake of alcoholic beverages
during the last year, with two categories heavy drinkers vs.
non- heavy drinkers. The type of last educational institu-
tion attended was used, giving two categories: lower (<7years of education), and higher (including secondary (7 to
14 years) and university (more than 14 years) levels]. The
Sub-Saharan Africa Activity Questionnaire (SSAAQ) [8]
was used to assess the leisure time physical activity during
the past month. Frequency and duration were computed
for each reported activity, and the energy expenditure was
calculated using Ainsworth et al.’s compendium [9]. En-
ergy expenditure related to leisure time physical activity
was calculated by multiplying the ratio of the exercise to
resting metabolic rate (MET, Metabolic equivalent) score
by the number of hours spent in each activity. From the
total MET of each subject, we categorized physical activity
into strenuous vs. non-strenuous.
Height (to the nearest centimetre) and weight (to the
nearest kilogram) were measured using standard methods
and body mass index (BMI) calculated for all subjects.
They were classified as underweight (BMI <18.5 kg/m2),
normal weight (BMI ≥18.5 and BMI <25 kg/m2), over-
weight (BMI ≥25 kg/m2 and BMI <30 kg/m2) and obese
(BMI ≥30 kg/m2). Waist circumference was measured to
the nearest 0.1 cm at the level of the iliac crest at the end of
normal respiration [10,11]. Waist to hip ratio (WHR) was
the waist circumference divided by the hip circumference.
Measurement of cardiometabolic components
The four metabolic components measured include ele-
vated blood pressure; elevated levels of triglycerides
(≥150 mg/dL or 1.69 mmo/L), fasting plasma glucose
(≥100 mg/dl or 5.6 mmol/L or documented use of anti-
diabetic medications), and elevated homeostasis model
assessment of insulin resistance value (HOMA-IR > 90th
percentile). Seated (after at least 30 minutes) diastolic
(DBP) and systolic (SBP) blood pressures were measured
using a mercury sphygmomanometer with three record-
ings on the right arm using a standard mercury sphygmo-
manometer and appropriate cuff sizes. The average of the
second and third measures was used to define hyperten-
sion. Elevated BP was defined as: SBP ≥ 140 mmHg, and/
or DBP ≥ 90 mmHg, or use of blood pressure lowering
drugs. The OGTT was performed according to the World
Health Organization (WHO) protocol [12], with the sub-
jects ingesting glucose in 300 ml of chilled water corre-
sponding to 75-g of anhydrate glucose (Plantecam/
Medicam, Mutengene, Cameroon). Venous blood samples
were collected after an overnight fast of at least 12 hours
for the determination of plasma glucose, insulin, and tri-
glycerides levels. Samples for insulin determination were
collected on ice, centrifuged immediately, separated and
stored at −70°C until assayed. Fasting plasma glucose
(FPG) was determined by the glucose-oxidase method
using a spectrophotometer with external quality control
on every 4th sample by a Cobas bio hexokinase fluoromet-
ric method. Plasma insulin was assayed at the Welcome
Laboratories, University of Newcastle Upon Tyne, by
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erides were measured by enzymatic colorimetric methods
in the same laboratory. Homeostasis assessment model for
insulin resistance (HOMA-IR) was used to evaluate insu-
lin resistance using the following formula: Fasting plasma
glucose (mmol/l) × Fasting plasma insulin (μU/ml)/22.5.
Body size phenotype definitions
No standardized definition of body size phenotypes exists.
Hence, for the present analyses, four metabolic abnormal-
ities were considered (elevated blood pressure; elevated
triglyceride and glucose levels; insulin resistance). Body
size phenotypes were defined based on the combined con-
sideration of BMI category (normal weight, overweight,
and obesity) and having 0 to 1 (metabolically healthy) or 2
or more (metabolically abnormal) cardiometabolic abnor-
malities. The categories were normal weight and metabol-
ically healthy (BMI < 25.0 kg/m2 and < 2 cardiometabolic
abnormalities), normal weight and metabolically abnormal
(BMI < 25.0 kg/m2 and ≥ 2 cardiometabolic abnormalities),
overweight, metabolically healthy (BMI 25.0-29.9 kg/m2
and <2 cardiometabolic abnormalities), overweight and
metabolically abnormal (BMI 25.0-29.9 kg/m2 and ≥ 2
cardiometabolic abnormalities), obese and metabolic-
ally healthy (BMI ≥ 30.0 kg/m2 and <2 cardiometabolic
abnormalities), and obese and metabolically abnormal
(BMI ≥30.0 kg/m2 and ≥2 cardiometabolic abnormalities).
Statistical analysis
Participant characteristics are presented as means (stand-
ard deviation) or median (interquartile range) or percent-
ages, by site of residence (urban vs. rural) and by body size
phenotype. Pairwise comparisons within BMI category,
for metabolically healthy and metabolically abnormal in-
dividuals were tested using chi square tests, and t-tests
and non-parametric equivalents as appropriate. The linear
trends across BMI categories, separately for metabolic-
ally healthy and metabolically abnormal participants
were tested via Cochran-Artmitage trend tests, and
Brown-Forsythe Levene procedures. Two-ways interac-
tions between BMI categories and metabolic status, and
between setting (rural or urban) and metabolic status were
tested as well as the 3-ways interaction setting (rural or
urban), BMI categories, and metabolic status. A two-sided
p-value < 0.05 was used to define statistical significance.
All analyses were conducted using the Statistical Package
for Social Sciences (SSPS Inc., Chicago, IL) version 17.0
software.
Results
Participant’s characteristics
As shown in Table 1, compared to urban dwellers those
living in the rural settings were more likely to be older
(45.9 vs. 37.6 years, p < 0.001), of lower socio-economicstatus (93.2% vs. 45.6%, p < 0.001) and more physically
active (57.2 vs. 37.8, p < 0.001); but less likely to be edu-
cated (secondary education or more: 20.2% vs. 89.8%, p <
0.001), have higher diastolic blood pressure (72 vs. 77
mmHg, p < 0.001), be on antihypertensive drugs or have
hypertension (5.3% vs. 9.9%, p = 0.001), be obese (as esti-
mated by BMI and WHR; both p < 0.001) or glucose in-
tolerant or insulin resistant (both p < 0.001).
Prevalence of body size
Among the investigated adult Cameroonians (aged 24 to
74 years), 25.2% were overweight yet metabolically healthy
(0 or 1 metabolic abnormality) and 10.1% were obese yet
metabolically healthy, whereas 1.4% were normal weight
but metabolically abnormal (≥2 metabolic abnormalities).
Among rural dwellers, the proportion of abnormal meta-
bolic phenotype across normal-weight, overweight, obese
categories were 2.9%, 0.8%, 0.3%, respectively; the corre-
sponding values for urban dwellers were 0 .3%, 2.2% and
2.6% (Figure 1). The proportion of metabolically abnormal
participants increased significantly across BMI categor-
ies overall in a linear fashion (both p < 0.001), primar-
ily driven by significant (p < 0.001) and linear increase
(p < 0.001 for linear trend) in urban participants and
linear decrease (p = 0.036) among rural participants, with
significant interaction by setting (p < 0.001).
Characteristics of metabolic profiles within BMI categories
Within BMI categories, metabolically abnormal partici-
pants were older (all p ≤ 0.024), and as expected had
higher SBP and DBP (all p < 0.001), fasting and 2-hour
post load glucose (p < 0.001), HOMA-IR (all p < 0.024)
and high prevalence of hypertension or diabetes (both p <
0.001). They also tended to have higher waist circumfer-
ence (all p ≤ 0.049), comprise more women (all p ≤ 0.073)
and to have higher C-peptide levels (among overweight
and obese only, both p ≤ 0.001). Furthermore, in the obese
sub-group BMI tended to be higher among metabolically
abnormal participants (34.3 vs. 33.0, p = 0.066), while in
the normal weight subgroup metabolically abnormal were
less likely to be educated (27.8% vs. 53.8%, p = 0.025) and
more often heavy drinkers (31.8% vs. 14.7%, p = 0.036),
Table 2.
Characteristics by metabolic profile across BMI categories
The proportion of men decreased from 54.3% in the
normal-weight healthy subjects to 23.9% in the obese
healthy group (p < 0.001 for linearity), while it was ap-
proximately the same among normal-weight and obese
metabolically abnormal subjects (36.4% vs. 37.0%), but
higher in the overweight metabolically abnormal subjects
(65.4%) with non-significant linear trend (p = 0.054). Age
decreased linearly across BMI categories among metabol-
ically abnormal subjects (p = 0.01), but not among the
Table 1 Baseline characteristics of participants (urban vs. rural)*
Variables Overall Rural Urban p-value
N 1628 669 959
Men, n (%) 691 (42.4) 272 (40.7) 419 (43.7) 0.223
Age, years (SD) 41.0 (11.7) 45.9 (13.3) 37.6 (9.1) <0.001
Systolic blood pressure, mmHg (SD) 117 (18) 117 (20) 117 (17) 0.991
Diastolic blood pressure, mmHg (SD) 75 (13) 72 (12) 77 (13) <0.001
Body mass index, kg/m2 (SD) 24.5 (4.4) 22.1 (3.1) 26.1 (4.5) <0.001
Waist circumference, cm (SD) 82 (9) 82 (9) 82 (10) 0.050
Waist-to-hip ratio (SD) 0.85 (0.12) 0.81 (0.07) 0.91 (0.15) <0.001
Fasting blood glucose, mmol/L (SD) 4.2 (1.5) 4.2 (1.6) 4.2 (1.4) 0.261
2h glucose, mmol/L (SD) 5.1 (2.0) 5.0 (1.7) 5.3 (2.3) 0.002
Triglycerides, mmol/L (SD) 0.53 (0.31) 0.52 (0.26) 0.54 (0.34) 0.522
Total cholesterol, mmol/L (SD) 3.1 (0.9) 3.6 (0.7) 3.5 (0.9) <0.001
Fasting insulin, U/L [25th-75th percentiles] 3.7 [2.2-6.0] 2.4 [1.4-3.7] 4.8 [3.3-7.1] <0.001
Fasting c-peptide, U/L [25th-75th percentiles] 0.28 [0.19-0.40] 0.23 [0.16-0.34] 0.31 [0.21-0.43] <0.001
Total energy, METs (SD) 3726 (1516) 4087 (1704) 3491 (1316) <0.001
HOMA-IR, Units [25th-75th percentiles] 0.67 [0.39-1.12] 0.42 [0.26-0.68] 0.88 [0.57-1.35] <0.001
Education (secondary or more), n (%) 979 (62.4) 125 (20.2) 854 (89.8) <0.001
Low socio-economic status, n (%) 1057 (65.1) 620 (93.2) 437 (45.6) <0.001
Heavy drinker, n (%) 208 (12.8) 150 (22.6) 58 (6.1) <0.001
Smoking, n (%) <0.001
Never 1366 (84.1) 579 (86.9) 787 (82.2)
Ex-smoker 92 (5.7) 14 (2.1) 78 (8.1)
Current smokers 166 (10.2) 73 (11.0) 93 (9.7)
Strenuous physical activity, n (%) 747 (45.9) 383 (57.2) 363 (37.8) <0.001
Any Diabetes, n (%) 65 (4.0) 33 (5.0) 32 (3.3) 0.102
Any hypertension, n (%) 130 (8.0) 35 (5.3) 95 (9.9) 0.001
*Values are means and standard deviation (SD), median and 25th-75th percentiles or count and percentages.
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cumference, total cholesterol, fasting insulin, fasting C-
peptide, HOMA-IR and education level increased in linear
fashions (all p < 0.032) while socio-economic status (all
p < 0.003) linearly decreased across BMI categories in
both metabolically health and abnormal participants
(Table 2). Hypertension rate (p < 0.001), diabetes fre-
quency (p = 0.032), heavy drinking (p = 0.001), total energy
intake (p < 0.001) and waist-hip-ratio (p < 0.001) linearly
decreased across BMI categories among metabolically nor-
mal subjects, while the pattern was always non-significant
among metabolically abnormal subjects (all p > 0.05 for lin-
ear trend), Table 2.
Interactions by BMI, metabolic status and study setting
(rural or urban)
There was significant interaction between BMI categories
and metabolic status in the distribution of gender (p =
0.002), age (p = 0.014), BMI (p = 0.044), fasting and 2 h
post load glucose (both p < 0.001), triglycerides (p < 0.001),fasting C-peptide (p = 0.012) and hypertension (p = 0.015).
Furthermore, significant interactions were observed be-
tween metabolic status and setting (rural vs. urban) in the
distribution across BMI categories of diastolic blood pres-
sure (p = 0.004), BMI and waist circumference (both p <
0.001), waist-to-hip ratio (p = 0.006), fasting 2-hour post
load glucose (both p < 0.003), triglycerides (p = 0.002), fast-
ing c-peptide and HOMA-IR (both p = 0.027), and preva-
lent diabetes (p = 0.041), Table 2. There was also evidence
of significant 3-ways interaction setting*[BMI categories]
*metabolic status in the distribution of many characteris-
tics as shown in Table 2, clearly indicating that most of
the variations observed across BMI categories and meta-
bolic status were occurring in differential ways among
urban and rural participants.
Discussion
Our study shows that a considerable proportion of over-
weight or obese Cameroonian adults are metabolically
healthy, whereas a sizable proportion of normal-weight
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Figure 1 Distribution of obesity phenotypes in urban and rural Cameroonians.
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of cardiometabolic abnormalities. Up to 85.8% of obese
Cameroonians possess a healthy profile, more so among
those living in rural areas than in urban areas, in terms
of the standard cardiometabolic risk factors. In contrast,
2.1% of normal-weight people exhibit clustering of car-
diometabolic abnormalities (i.e., ≥2 cardiometabolic ab-
normalities). This study also found significant differences
in the distribution of many characteristics across obesity
phenotypes, with strong indications that these differences
were occurring in differential ways between urban and
rural participants.
Our study is among the firsts to examine the concept
of metabolically healthy obesity in African populations,
and is relevant to the ongoing debate on the usefulness
of this concept. The prevalence of body size phenotypes
among African populations including the urban rural
differences, have seldom been investigated in studies [6].
Compared to studies conducted in other continents, and
despite differences in the definitions of “metabolically
healthy” that have been used, the prevalence of metabol-
ically healthy obese individuals is similar between the
present and previous studies, which found a prevalence
of 6 to 75% [6], depending on the definition used, andhigher in population of Asia descend than in Caucasian.
People of African descent have seldom been included in
existing studies. The prevalence of individuals who are
normal weight yet have metabolic abnormalities has
been less studied [13].
Interestingly, distributions of several characteristics across
body size phenotype were affected by place of residence.
Indeed, variations in BMI and metabolic status were func-
tion of the place of residence, with rural status tending to
confer a better metabolic profile. This observation will
need further confirmation on larger samples. The reasons
for this interesting observation remain unclear. However,
this suggests that BMI may not be the most appropriate
accurate measure of the adverse effects of excess adiposity
[14]. On may speculate that these differences may be re-
lated to lifestyle factors, namely diet and physical activity.
Hence the exploration of lifestyle characteristics may help
disentangle these issues. Also, contextual or environmen-
tal effects may play a role in the determining the extent of
cardiometabolic health among obese people. If this were
to be the case, it would call for tailoring of preventive
strategies depending on the setting.
Our study has limitations that merit consideration. Our
data was not representative of the entire Cameroonian
Table 2 Pairwise comparisons of metabolically healthy and metabolically abnormal participants with body mass index categories
Characteristics Normal-weight Overweight Obese P trend across BMI
categories
P interaction
Metabolic status Healthy Abnormal p Healthy Abnormal p Healthy Abnormal p Overall Healthy Abnormal B*M M*S B*M*s
Prevalence, n (%) 968 (60.0) 22 (1.4) 406 (25.2) 26 (1.6) 163 (10.1) 27 (1.7) <0.001 - - <0.001
Men 426 (54.3) 8 (36.4) 0.073 161 (39.7) 17 (65.4) 0.009 39 (23.9) 10 (37.0) 0.116 <0.001 <0.001 0.054 0.002 0.541 0.244
Age (years) 40.9 (12.9) 54.2 (10.8) <0.001 39.4 (9.1) 43.9 (10.2) 0.016 41.7 (9.3) 46.1 (9.4) 0.024 0.922 0.641 0.010 0.014 0.650 0.004
Systolic blood
pressure
114 (16) 146 (33) <0.001 118 (18) 141 (17) <0.001 122 (17) 143 (23) <0.001 <0.001 <0.001 0.643 0.082 0.421 0.049
Diastolic blood
pressure
72 (11) 83 (15) <0.001 77 (13) 93 (17) <0.001 80 (12) 94 (17) <0.001 <0.001 <0.001 0.032 0.477 0.004 0.060
Body mass index 21.7 (2.0) 21.5 (2.3) 0.729 27.0 (1.3) 27.2 (1.3) 0.525 33.0 (3.1) 34.3 (4.8) 0.066 <0.001 <0.001 <0.001 0.044 <0.001 0.021
Waist circumference 78 (7) 81 (6) 0.049 86 (7) 90 (6) 0.009 95 (9) 100 (9) 0.004 <0.001 <0.001 <0.001 0.513 <0.001 <0.001
Waist-hip-ratio 0.86 (0.12) 0.89 (0.04) 0.166 0.83 (0.09) 0.87 (0.05) 0.039 0.83 (0.10) 0.86 (0.09) 0.200 <0.001 <0.001 0.051 0.934 0.006 0.004
Fasting blood
glucose
4.0 (0.6) 7.6 (8.3) <0.001 4.2 (0.8) 6.3 (4.9) <0.001 4.1 (0.6) 5.7 (4.6) <0.001 0.008 0.008 0.304 <0.001 0.003 <0.001
2h glucose 4.9 (1.1) 12.4 (11.1) <0.001 4.9 (1.0) 9.6 (6.7) <0.001 5.0 (1.0) 7.9 (2.8) <0.001 0.006 0.134 0.048 <0.001 <0.001 <0.001
Triglycerides 0.51 (0.27) 0.55 (0.18) 0.408 0.54 (0.32) 1.06 (1.04) <0.001 0.58 (0.23) 0.72 (0.25) 0.004 <0.001 0.001 0.430 <0.001 0.002 <0.001
Total cholesterol 2.9 (0.8) 2.9 (0.9) 0.885 3.5 (0.9) 3.3 (0.8) 0.428 3.8 (0.9) 3.9 (0.7) 0.501 <0.001 <0.001 <0.001 0.568 0.407 0.109
Total energy 3857 (1579) 3704 (1449) 0.652 3574 (1408) 3380 (1029) 0.492 3435 (1396) 3438 (1185) 0.993 <0.001 <0.001 0.473 0.895 0.431 0.505
Fasting insulin 2.9 [1.8-4.6] 2.9 [2.1-11.9] 0.915 4.8 [3.3-6.7] 7.2 [6.0-13.9] <0.001 .0 [4.0-11.4] 15.2 [9.6-18.0] <0.001 <0.001 <0.001 <0.001 0.161 0.057 0.439
Fasting c-peptide 0.24 [0.17-0.34] 0.29 [0.22-0.68] 0.320 0.32 [0.22-0.44] 0.44 [0.32-0.62 0.001 0.37 [0.27-0.48] 0.71 [0.56-0.92] <0.001 <0.001 <0.001 0.001 0.012 0.027 0.194
HOMA_IR 0.52 [0.32-0.83] 1.22 [0.32-3.32] 0.024 0.88 [0.59-1.30] 2.28 [1.28-2.71] <0.001 1.11 [0.75-1.62] 3.12 [2.48-3.90] <0.001 <0.001 <0.001 0.003 0.118 0.027 0.222
Education (secondary
or more)
497 (53.8) 5 (27.8) 0.025 301 (75.1) 21 (80.8) 0.349 128 (80.0) 22 (84.6) 0.403 <0.001 <0.001 <0.001 0.090 0.262 0.423
Low socio-economic
status
723 (74.9) 19 (86.4) 0.164 208 (51.4) 7 (26.9) 0.013 77 (47.2) 11 (40.7) 0.339 <0.001 <0.001 0.003 0.063 0.869 <0.001
Heavy drinker 141 (14.7) 7 (31.8) 0.036 40 (9.9) 2 (7.7) 0.525 11 (6.7) 3 (11.1) 0.318 <0.001 0.001 0.062 0.354 0.805 0.142
Smoking 0.556 0.632 0.036 0.520 0.197 0.314 0.200 0.279 0.439
Never 816 (84.6) 17 (77.3) 337 (83.2) 23 (88.5) 142 (87.1) 18 (66.7)
Ex-smoker 40 (4.1) 2 (9.1) 35 (8.6) 1 (3.8) 10 (6.1) 3 (11.1)
Current smokers 109 (11.3) 3 (13.6) 33 (8.1) 2 (7.7) 11 (6.7) 6 (22.2)
Strenuous physical
activity
475 (49.1) 21 (54.5) 0.385 168 (41.4) 9 (34.6) 0.321 65 (39.9) 11 (40.7) 0.546 0.002 0.003 0.367 0.697 0.827 0.678
Any Diabetes 19 (2.0) 13 (68.4) <0.001 4 (1.0) 13 (50.0) <0.001 0 15 (55.6) <0.001 0.007 0.032 0.445 0.996 0.041 0.020
Any hypertension 34 (3.5) 10 (45.5) <0.001 36 (8.9) 11 (42.3) <0.001 26 (16.0) 11 (40.7) 0.005 <0.001 <0..001 0.744 0.015 0.378 0.036
Values are count (percentages, %), mean (standard deviation, SD) or median [25th – 75th percentiles]. B*M, interaction term of body mass index categories and metabolic status; M*S, interaction term of metabolic
status and setting (rural vs. urban); B*M*S, 3-ways interaction term of body mass index categories, metabolic status and setting. Units of measurements and other conventions are as per Table 1.
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1994, and the demographic and nutrition transition may
have led to different patterns of body size phenotypes in
the current Cameroonian population, especially as some
of the risk factors change over time [7,11]. However, this
time lag does not invalidate the relevance of our data; al-
though the contemporary proportions of people in various
phenotype categories may vary, it is highly likely that over
time the main change would be that more people would
have become obese especially in urban area. Body size
phenotype definitions have not been standardized, hence
the prevalence estimates are subject to alteration depend-
ing on the number of metabolic abnormalities considered
and the specific cut points of those abnormalities. In
addition, BMI as a measure of obesity has limitations
because it cannot distinguish between fat tissue and lean
tissue. Whether this limitation is pertinent for African
populations remains to be determined as the amount of
body fat per given BMI value in these populations com-
pared to other populations (e.g.; Western populations) re-
mains to be clarified [15-19]. A similar limitation exists
for waist circumference, as studies on African populations
have seldom examined the relation of abdominal visceral
to waist circumference [20], and its relation to outcomes.
Another limitation was the cross-sectional design of our
study, which precludes appropriate investigation and
causal attribution.
Despite the aforementioned limitations, our study had
a number of strengths. To our knowledge it is the first
of its kind on African populations on body size pheno-
types, and including a sizeable number of Cameroonians
with investigation of urban vs. rural contrast, with ro-
bust measures abnormal metabolism including glucose
intolerance through OGTT and insulin resistance.
Conclusions
In conclusion, the present data suggest that a substantial
proportion of individuals with normal-weight display
cardiometabolic abnormality clustering, as well as an im-
portant fraction of obese individuals who are metabolically
healthy. Additional and more representative, larger and
longitudinal studies, including behavioural, hormonal or
biochemical, and genetic factors, as well as relevant car-
diovascular outcomes among population of African des-
cent, which would help to designing and refining obesity
intervention targets and improving screening tools.
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